Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO)

International Journal of Artificial Organs

Volumn 25, Issue 12, 2002, Pages 1194-1198

  Di Paolo, Nicola ^a   Bocci, V ^b   Cappelletti, F ^a   Petrini, G ^a   Gaggiotti, E ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Necrotizing fasciitis; Ozone therapy

Indexed keywords

BLOOD; OXYGENATION; OZONE; OZONE WATER TREATMENT; RESPIRATORY THERAPY;

NECROTIZING FASCIITI; OZONE THERAPY; PATIENTS' CONDITIONS;

OZONIZATION;

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; CEFOTAXIME; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; CREATINE KINASE; DOPAMINE; FIBRINOGEN; LACTATE DEHYDROGENASE; MYOGLOBIN; OZONE; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BODY TEMPERATURE; BONE DISEASE; BONE PAIN; CASE REPORT; CELL DEATH; CIRCADIAN RHYTHM; DECUBITUS; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HEMODIALYSIS; HUMAN; HYPERPYREXIA; LEG PAIN; LEUKOCYTE; MAINTENANCE THERAPY; MYALGIA; NECROTIZING FASCIITIS; NEUTROPHIL; OZONATION; PATHOLOGY; SKIN BIOPSY; SKIN DEFECT; TREATMENT PLANNING; WOUND CARE;

EID: 0346665821     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501212     Document Type: Article

References (18)

1. McHenry CR, Piotrosky JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft tissue infections. Ann Surg 1995; 221: 558-63.
2. Giuliano A, Lewis F Jr, Hadley K, Blaisdell FW. Bacteriology of necrotizing fasciitis. Am J Surg 1977; 134: 52-7.
3. Rea WJ, Wyrick WJ. Necrotizing fasciitis. Ann Surg 1970; 172: 957-64.
4. Brook I, Fraizer EH. Clinical and microbiology features of necrotizing fasciitis. J Clin Microbiol 1995; 33: 2382-7.
5. Roujeau JC. Necrotizing fasciitis. Clinical criteria and risk factors. Ann Dermatol Venereol 2001; 128 (3 Pt 2): 376-81.
6. Hansmann Y. What data is needed today to deal with cellulitis and necrotizing fasciitis? Ann Dermatol Venereol 2001; 128 (3 Pt 2): 443-51.
7. Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis: The use of frozen-section biopsy. N Engl J Med 1984; 310: 1689-93.
8. Brun-Buisson C. The therapeutic approach to necrotizing fasciitis. Ann Dermatol Venereol 2001; 128: (3 Pt 2): 394-403.
9. Derancourt C. Management of necrotizing cellulitis and fasciitis. Ann Dermatol Venereol 2001; 128 (3 Pt 2): 452-7.
10. Bocci V, Di Paolo N, Garosi G, et al. P. Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies. Int J Artif Organs 1999; 22: 645-51.
11. Di Paolo N, Bocci V, Garosi G, et al. Extracorporeal blood oxigenation and ozonation (EBOO) in man. Preliminary report. Int J Artif Organs 2000; 23: 131-41.
12. Bocci V, Di Paolo N, Borrelli E, Larini A, Cappelletti F. Ozonation of blood during extracorporeal circulation II. Comparative analysis of several oxygenators-ozonators and selection of one type. Int J Artif Organs 2001; 24: 890-7.
13. Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J Biol Regul Homeost Agents 1996; 10: 31-53.
14. Bocci V. Biological and clinical effects of ozone. Has ozonetherapy any future in medicine? Br J Biomed Sci 1999; 56: 270-9.
15. Bocci V, Aldinucci C, Borrelli E, Corradeschi F, Diadori A, Fanetti G, Valacchi G. Ozone in medicine. Ozone-Sci Eng 2001; 23: 207-17.
16. Bocci V. Ossigeno-Ozono Terapia. Milano: Casa Editrice Ambrosiana, 2000.
17. Pryor WA. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radic Biol Med 1994; 17: 451-65.
18. Valacchi G, Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediat Inflamm 1999; 8: 205-9.